Navigation Links
GENova appoints Dr. Philip Gould to Scientific Advisory Board

NEW YORK, NY, Sept. 13 /PRNewswire-FirstCall/ - (OTCBB: GVBP.OB) - GENova Biotherapeutics, Inc., ("GENova"), a biotechnology company that identifies, acquires, and develops novel drug targets that disrupt the advance of life-threatening diseases, today announced it has appointed Dr. Philip Gould as a Member Designate of its Scientific Advisory Board (SAB).

Dr. Gould will contribute his career experience in multinational blue chip drug discovery companies as well as his drug patenting experience to GENova's business of identifying, evaluating and developing pioneering research drugs

Aaron Whiteman, CEO of GENova, says, "Mr. Gould's esteemed position as an international business leader in the healthcare and drug development sectors is an asset to GENova."

About Dr. Philip Gould

Mr. Gould is presently the Chief Business Officer of the Liverpool School of Tropical Medicine, the first institution of its kind dedicated to research in tropical medicine. He also maintains his position as Founder and CEO of Jadara Pharma Ltd, a profitable healthcare business consultancy with contracts in strategic business planning, fund raising, patent litigation, strategic product development, spin out portfolio management and investor support to trade sale or IPO. Previously, he was CEO of Provalis plc, a pharmaceutical and medical diagnostics company. Other positions have included Principle Research Scientist and Senior Manager of Pharmaceutical Development for Pfizer, and Head of New Product Development for GlaxoSmithKline.

He has produced over 20 publications as a primary author, and has presented 25 papers at seminars on a variety of both technical and managerial subjects, and has been named as an inventor on 4 patents. He holds a Ph.D in Physical Chemistry.

About GENova Biotherapeutics Inc.

GENova is positioning itself as the world's leading bioscience company in the development and commercial licensing of novel therapeutic proteins that disrupt the advance of life-threatening cancers. The company leverages cutting-edge research collaborations to achieve breakthroughs in anti-cancer treatments, and then licenses these patented drug product candidates to Big Pharmaceutical and Biotechnology companies such as Pfizer (NYSE: PFE), Amgen (Nasdaq: AMGN), Myriad Genetics (Nasdaq: MYGN), Medarex (Nasdaq: MEDX), and Biogen Idec (Nasdaq: BIIB) . Visit GENova online at

Forward Looking Statements

This document includes certain statements that may be deemed to be "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, are expected by the Company to be forward-looking statements. Although GENova believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in the forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include but are not limited to the success of the owned intellectual property, the strength of the patents, continued availability of capital and financing, and general economic market or business conditions.

SOURCE GENova Biotherapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. GENova names Aaron Whiteman as CEO
2. GENova names Dr. John Savin as Vice President
3. Genova files patent for new prostate cancer treatment
4. GENova appoints Dr. Anders Boegh Jensen to Scientific Advisory Board
5. GENova discusses development of new anti-cancer biotechs potentially worth $400 Million per annum
6. GENova appoints Director of Asian business development
7. GENova files patent for new breast cancer treatment
8. GENova to acquire three new drug target patents worth in excess of $1 billion in royalty fees
9. GENova issues clarifying press release
10. WorldHeart Appoints David Pellone Chief Financial Officer
11. Novo Nordisk Appoints New Leader of North American Business
Post Your Comments:
(Date:11/30/2015)... Ill. (PRWEB) , ... November 30, 2015 , ... ... Decision Support Solutions, announced at the Radiology Society of North America (RSNA) annual ... have seen over 60% growth from 2014. Throughout 2015, the company has ...
(Date:11/30/2015)... ... November 30, 2015 , ... Since its inception, Seniors Guide ... living, assisted living and all other retirement options. Support for issues surrounding the ... remains a top priority. , So it’s no surprise that every November, ...
(Date:11/30/2015)... Washington, DC (PRWEB) , ... ... ... Services, Inc. (AIS) is pleased to announce the speakers for “Value-Based Payer-Provider ... valuable lessons learned from three innovative value-based care arrangements: Essentia Health and ...
(Date:11/30/2015)... PA (PRWEB) , ... November 30, 2015 , ... ... software provider, has verified that their Vasont Universal Integrator (VUI) extension unites with ... creating, editing, and managing content as a continuous process with the latest release ...
(Date:11/30/2015)... ... 30, 2015 , ... Scott Newman MD, FACS of New ... plastic surgeons in the New York City area to utilize the new, non-invasive ... heat-induced laser treatment for fat loss in the abdomen, flanks, and other areas ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... and REHOVOT, Israel , Nov. 30, ... company focused on acquiring and developing innovative therapies for ... appointment of Keith A. Katkin as chairman ... J. Flesher , chief executive officer for OticPharma, Ltd.  ... organizations.  As chairman, he will be able to share ...
(Date:11/29/2015)... , Nov. 29, 2015  Strengthening its leadership ... PHG, AEX: PHIA) today announced IntelliSpace Portal 8.0 ... analytics and visualization platform that helps radiologists detect, diagnose ... 2015 Radiological Society of North America Annual Meeting ... IntelliSpace Portal 8.0 helps address the changing demands in ...
(Date:11/29/2015)... -- The GE Health Cloud 1 was unveiled today at ... North America (RSNA) meeting in Chicago ... cloud ecosystem and its applications will connect radiologists and clinicians ... teams – both inside and outside the hospital setting. ... "As the digital industrial leader, we are betting big on ...
Breaking Medicine Technology: